Perhaps there will be additional funding for FeLV research resulting from this 


- Lorraine



If your email program has trouble displaying this email, view it as a web page 




FDA Increases Total Individual Award Amount for Minor Use/Minor Species Grants


Application period opens June 14, 2019


The U.S. Food and Drug Administration today announced an open period for 
applications for grants to support the development and approval or conditional 
approval of new animal drugs intended to treat uncommon diseases (minor uses) 
in major species (horses, dogs, cats, cattle, pigs, turkeys and chickens) or to 
treat minor species (MUMS). The individual award amount has been increased to a 
single funding level up to $250,000.


The Minor Use and Minor Species Animal Health Act of 2004 (the MUMS act) 
provides innovative ways to bring products to market for these small 
populations and is designed to help veterinary pharmaceutical companies and 
others overcome the financial roadblocks they face in providing animal drugs 
for a limited market. Before this legislation, veterinary pharmaceutical 
companies and others would rarely attempt to bring such drugs to market. The 
MUMS act established the grant program.


Grants awarded through the MUMS program support the FDA’s continuing mission to 
assure that safe and effective animal drugs are available for a wide range of 
species and conditions.


 Read more 






U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy 


Felvtalk mailing list

Reply via email to